Treatment of various B-CLL cell lines (B cell chronic lymphocytic leukemia), which are deficient in p53-dependent apoptosis, with roscovitine results in p53-independent apoptosis within 24 h of treatment due to decreased expression of genes involved in transcription, translation, survival, and DNA repair [97]. The gene discussed is TP53; the disease is B-cell chronic lymphocytic leukemia.